Gesynta Pharma AB is a startup based in Sweden, 1 tracked investor.
Gesynta Pharma AB is a startup founded in 2016 based in Sweden. Brouky records 1 investor associated with the company.
Gesynta Pharma is a clinical-stage pharmaceutical company developing novel treatments for microvascular diseases. Their lead candidate, GS-248, targets microvascular angina.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.